Skip to main content

WEBINAR

THUR, NOV 14 2024 · 15:00-16:00 GMT

Weather, Elections and Clinical Trials: Some novel approaches to visualizing uncertainty

Can’t make it to the live session? Register to receive access to the recorded version.

What do weather systems, voting intentions and clinical trials have in common? They all use data in order to make some kind of inference or prediction, but with this comes a degree of uncertainty. How sure can we be about the conclusions or predictions? Being able to communicate uncertainty is important for drawing conclusions or making decisions but it can be challenging to do it well.

In this webinar, we will explore some novel approaches to data visualization used in meteorology and election polling, and apply these to the results of a well-publicized clinical trial. Which methods are most effective? That depends on the eye of the beholder, and we include several interactive polls so you’ll get the chance to have your say. The webinar concludes with a panel discussion, where we’ll explore the different perspectives of statisticians and medical practitioners.

Agenda:

  • Prediction of US Elections 2016 and 2020
  • Prediction of Hurricane Milton
  • EMBRACE case study
  • Intervals and distributions
  • Using obscurity to represent uncertainty
  • Use of animation
  • Panel discussion and Q&A

If you’re interested in data visualization, presenting data to non-statisticians or would like to learn more, please register to secure your spot!

The presenters

Steve Mallett

Senior Manager, Statistics, Veramed

Steve has over 25 years of experience in the pharma industry as a programmer and statistician and has a longstanding interest in data visualization as a tool for discovering and communicating trends and patterns in clinical data. Steve has developed and presented a number of training courses, produced guidance on good graphics principles, and has spoken at several conferences, podcasts and webinars.

Jan de Witt

Consultant, Clinical Development

Jan de Witt is a medical doctor by training (University Leiden, The Netherlands). Jan spent more than 35 years in the pharmaceutical and CRO business-environment and has fulfilled many global jobs, varying from general management, strategic business development, corporate development, medical affairs and clinical development. In December 2023, he retired as Vice President Therapeutic Area Head at Fortrea CRO and since early 2024 Jan joined Veramed as consultant for the role of Strategic Ambassador.

Paolo Eusebi

Senior Consultant, Statistics & Psychometrics, IQVIA
Paolo has over 20 years of academic, pharmaceutical, and consulting experience. As Senior Consultant at IQVIA, he currently oversees patient centred solutions projects including development and validation of COAs, and analysis and reporting of PRO data. He has worked on neurology, oncology, and rare disease projects. Prior to joining PCS at IQVIA, Paolo was Associate Director at Modus Outcomes and worked as statistical consultant for academic centres and public bodies. He has also led and co-led led several research projects funded by the Italian Ministry of Health and the European Commission. Paolo is a co-author of many peer-reviewed publications and has presented his work at many international scientific conferences. His main research interests are patient-reported outcomes, subgroups identification, and data visualization. He is an active member of the Society for Advanced Methods in Epidemiology and Diagnostics (SBED) and the Statisticians in the Pharmaceutical Industry (PSI).

Meet Veramed

Veramed is a pioneering CRO redefining intelligent healthcare decision-making through end-to-end biometrics. We bring together people, innovation, and technology together with world-class governance to accelerate evidence generation and advance patient health. With skilled statisticians and programmers uniquely matched and scaled to client needs, we produce exceptional deliverables swiftly using a blend of skill, rigorous governance, and automation to optimize the speed and success of clinical research from design to submission and beyond.